AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 29 filers reported holding AVALO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3,964,666 | $19,982,313 | 0.35% |
| Nantahala Capital Management | 540,667 | $2,725,016 | 0.18% |
| Point72 Asset Management, L.P. | 500,737 | $2,523,765 | 0.01% |
| MEEDER ASSET MANAGEMENT INC | 1,507 | $7,595 | 0.00% |
| Assenagon Asset Management S.A. | 15,646 | $79 | 0.00% |
| VANGUARD GROUP INC | 222,073 | $1,119,271 | 0.00% |
| TCI Wealth Advisors, Inc. | 251 | $1,265 | 0.00% |
| UBS Group AG | 6,177 | $31,132 | 0.00% |
| OSAIC HOLDINGS, INC. | 1 | $0 | 0.00% |
| FMR LLC | 13 | $66 | 0.00% |